Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs
Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”
Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.
The cost of a Rhabdomyosarcoma (RMS) in India typically ranges between USD 5000 depending on the patient's condition, treatment plan (surgery, chemotherapy, radiation therapy) and hospital facilities. This procedure is often used to diagnose or eliminate cancer tumors, preventing the spread of tumors to other organs.
The following factors influence the cost of rhabdomyosarcoma (RMS) :
| City | Cost (USD) | |
|---|---|---|
| Ahmedabad | $4,500 | Explore More |
| Bangalore | $5,000 | Explore More |
| Chennai | $5,000 | Explore More |
| Delhi | $5,000 | Explore More |
| Faridabad | $5,000 | Explore More |
| Ghaziabad | $5,000 | Explore More |
| Gurgaon | $5,000 | Explore More |
| Gurugram | $5,000 | Explore More |
| Hyderabad | $5,000 | Explore More |
| Kochi | $5,000 | Explore More |
| Kolkata | $5,000 | Explore More |
| Mohali | $4,500 | Explore More |
| Mumbai | $5,000 | Explore More |
| Noida | $5,000 | Explore More |
| Panjim | $4,500 | Explore More |
| Pune | $4,500 | Explore More |
Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.
Commonly affecting children and young adults, rhabdomyosarcoma (RMS) is an uncommon and aggressive form of soft tissue cancer that arises in skeletal muscle cells. Treatment for rhabdomyosarcoma (RMS) includes radiation therapy to stop recurrence, chemotherapy to reduce or eradicate cancer cells, and surgery to remove the tumor. In certain situations, immunotherapy or targeted therapy may be employed. Rehabilitation and pain management are supportive care that enhances a patient's quality of life.
Rhabdomyosarcoma (RMS) is a rare cancer that develops from skeletal muscle cells. Treatment aims to kill cancer cells, stop the disease from spreading to other organs, alleviate symptoms, and maintain normal body function. Remission, decreased return risk, and improved longevity and quality of life are treatment goals, regardless of whether the tumour is contained or has spread, particularly in children and young adults, where RMS is more prevalent.
See a doctor if you experience symptoms like eye bulging or urinary issues, unexplained bleeding from body openings, pain in a particular place, or a quickly increasing lump or swelling. Early diagnosis greatly enhances treatment results. The experienced oncology staff at MediGence can help with timely assessment and individualised treatment.
Imaging tests such as MRIs, CT scans, PET scans, and biopsies confirm the diagnosis and RMS subtype (embryonal, alveolar, or other). Blood tests, lumbar punctures, and bone marrow biopsies are possible further procedures to determine the degree of dissemination. Your care team should be informed of your child's or your complete medical history, prescription drugs, and any lingering health conditions.
RMS treatment usually lasts 6 to 12 months, with surgery requiring a short hospital stay and chemotherapy or radiation given over multiple sessions. Long-term recovery and monitoring may continue for several years.
Treatment for RMS can result in long-term remission with a multidisciplinary approach, particularly in localised cases. Surgery removes visible tumours, radiation improves local control, and chemotherapy aids in the management of microscopic disease. Modern methods also seek to reduce long-term side effects and maintain organ function to ensure a higher quality of life after treatment.
The tumour site and level of treatment impact recovery. Wound care, physical therapy, and pain control are all part of post-surgery treatment. Routine monitoring is necessary to control side effects during radiation or chemotherapy. Physical examinations, imaging, and monitoring for late effects, such as hormonal or heart problems, are all part of long-term follow-up.
Alveolar and metastatic types of RMS have worse 5-year survival rates than localised embryonal RMS, which has a 70–90% survival rate. Treatment advancements, particularly in the areas of early detection and specialised care, have greatly enhanced results.
Delhi, India
Ghaziabad, India
Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.
✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours
Your medical info has is HIPAA-style confidential. We never share with hospitals without your consent.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…
This was the case with a 60-year-old cervical cancer patient from Nigeria, Mrs. Affiong Uko Henshaw. She was diagnosed with…
Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.
Upload Your Reports
